BrightSpring Health Services Inc(BTSG) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
September 11 at 5:05 PM ET (Korea 9/12 06:05)
Full metrics table
| Index | RUT | P/E | 43.86 | EPS (ttm) | 1.34 | Insider Own | 15.15% | Shs Outstand | 197.5M | Perf Week | -4.4% |
| Market Cap | 11.62B | Forward P/E | 25.46 | EPS next Y | 26.86% | Insider Trans | -49.74% | Shs Float | 167.9M | Perf Month | -1.59% |
| Enterprise Value | 13.47B | PEG | 0.62 | EPS next Q | 0.47 | Inst Own | 92.22% | Short Float | 6.04% | Perf Quarter | -6.9% |
| Income | 0.29B | P/S | 0.81 | EPS this Y | 81.81% | Inst Trans | 12.38% | Short Ratio | 2.93 | Perf Half Y | 51.99% |
| Sales | 14.37B | P/B | 5.66 | EPS next 5Y | 41.1% | ROA | 4.17% | Short Interest | 10.15M | Perf YTD | 56.82% |
| Book/sh | 10.37 | P/C | 21.11 | EPS past 3/5Y | - -20.78% | ROE | 13.11% | 52W High | -20.37% ($73.75) | Perf Year | 109.82% |
| Cash/sh | 2.78 | P/FCF | 29.13 | Sales past 3/5Y | 18.69% 18.27% | ROIC | 6.77% | 52W Low | 126.49% ($25.93) | Perf 3Y | - |
| Dividend Est. | - | EV/EBITDA | 19.51 | EPS Y/Y TTM | 350.11% | Gross Margin | 12.38% | Volatility(W/M) | 4.36% 3.96% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | 0.94 | Sales Y/Y TTM | 19.91% | Oper. Margin | 3.68% | ATR (14) | 2.57 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 1.22 | EPS Q/Q | 201.76% | Profit Margin | 2.05% | RSI (14) | 44.05 | Recom | 1.1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.59 | Sales Q/Q | 23.05% | SMA20 | -2% ($59.93) | Beta | 1.86 | Target Price | $78.94 |
| Payout | - | Debt/Eq | 1.17 | Earnings | 2026/7/31 | SMA50 | -8.77% ($64.38) | Rel Volume | 0.72 | Prev Close | $57.88 |
| Employees | 23500 | LT Debt/Eq | 1.12 | EPS/Sales Surpr. | 13.55% 5.8% | SMA200 | 15.91% ($50.67) | Avg Volume(3M) | 3.46M | Price | $58.73 |
| IPO | 2024/1/26 | Option/Short | Yes/Yes | Trades | 22266 | Volume | 2,489,800 | Change | 1.47% |
Company
BTSG is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
A US-based home and community health services company that provides specialty pharmacy dispensing and delivery, home health nursing visits, and personal care services for seniors and individuals with disabilities. Operating as a home- and community-focused healthcare services provider, it is positioned to benefit from the aging population and the growing shift toward home-based care.
Over the past 1 year, roughly in the middle
20% below its 1-year high.
BTSG makes money exceptionally well
3.68% of revenue is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +81.8% this year.
Tap to view numbers
The price looks about right
Trading at 43.9 times earnings.
Tap to view numbers
Results came in about as expected
Slight tendency to beat estimates
Tap to view numbers
The outlook is positive
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have paid off
Tap to view numbers
Dividends are hard to expect
This stock does not pay dividends
Ownership looks stable
Institutions hold 92.2%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
SGRT 0.05%
PSCH 0.04%
IPO 0.03%
ASD 0.03%
SAWS 0.03%It ranks #2 in the industry
Based on market cap of $12B.
BTSG $12B PER 43.9
VEEV $42B PER 43.2
TEM $11B PER -
HQY $8B PER 34.8
FAQ
What kind of company is BTSG?
BTSG belongs to the Healthcare sector and operates in the Health Information Services industry.
What is the market cap of BTSG?
The market cap of BTSG is approximately $11.6B, ranking 858 within its sector.
What is the P/E ratio of BTSG?
BTSG has a P/E ratio of approximately 43.9x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for BTSG?
BTSG has recorded a 52-week high of $73.75 and a low of $25.93.
